1. Home
  2. EQT vs TEVA Comparison

EQT vs TEVA Comparison

Compare EQT & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQT
  • TEVA
  • Stock Information
  • Founded
  • EQT 1925
  • TEVA 1901
  • Country
  • EQT United States
  • TEVA Israel
  • Employees
  • EQT N/A
  • TEVA N/A
  • Industry
  • EQT Oil & Gas Production
  • TEVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • EQT Energy
  • TEVA Health Care
  • Exchange
  • EQT Nasdaq
  • TEVA Nasdaq
  • Market Cap
  • EQT 23.4B
  • TEVA 23.7B
  • IPO Year
  • EQT N/A
  • TEVA N/A
  • Fundamental
  • Price
  • EQT $52.93
  • TEVA $21.83
  • Analyst Decision
  • EQT Buy
  • TEVA Buy
  • Analyst Count
  • EQT 18
  • TEVA 7
  • Target Price
  • EQT $49.82
  • TEVA $22.43
  • AVG Volume (30 Days)
  • EQT 7.3M
  • TEVA 8.9M
  • Earning Date
  • EQT 02-18-2025
  • TEVA 01-29-2025
  • Dividend Yield
  • EQT 1.21%
  • TEVA N/A
  • EPS Growth
  • EQT N/A
  • TEVA N/A
  • EPS
  • EQT 0.67
  • TEVA N/A
  • Revenue
  • EQT $4,623,048,000.00
  • TEVA $16,772,000,000.00
  • Revenue This Year
  • EQT $13.85
  • TEVA $5.74
  • Revenue Next Year
  • EQT $31.06
  • TEVA $4.46
  • P/E Ratio
  • EQT $79.77
  • TEVA N/A
  • Revenue Growth
  • EQT N/A
  • TEVA 9.81
  • 52 Week Low
  • EQT $30.02
  • TEVA $11.48
  • 52 Week High
  • EQT $53.98
  • TEVA $22.80
  • Technical
  • Relative Strength Index (RSI)
  • EQT 73.62
  • TEVA 60.46
  • Support Level
  • EQT $48.79
  • TEVA $21.21
  • Resistance Level
  • EQT $53.98
  • TEVA $22.10
  • Average True Range (ATR)
  • EQT 1.30
  • TEVA 0.62
  • MACD
  • EQT 0.54
  • TEVA -0.11
  • Stochastic Oscillator
  • EQT 85.09
  • TEVA 69.42

About EQT EQT Corporation

EQT Corp is an independent natural gas production company with operations focused in the cores of the Marcellus and Utica shales in the Appalachian Basin, located in the Eastern United States. The firm focuses on executing combo-development projects for developing multiwell pads to meet supply needs, with a focus on maximizing operational efficiency, technology, and sustainability. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has one reportable segment and its revenue stems from three types of gas reserves: natural gas, natural gas liquids, and crude oil. All of the firm's operating revenue is generated in the U.S., with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: